ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992

Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available

January 12, 1990

NCI Rethinks Cancer Center Grants

March 14, 2014

Funding opportunities listed.

November 19, 2004

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

AMC Cancer Center, Rose Cancer Program Name Douglass Tormey Director; ECG Plans Move To Denver

September 4, 1992